PAVmed Inc
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
PAVM$1.56-4.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Years Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Cash flows from operating activities | ||
| Net loss - before noncontrolling interest (“NCI”) | $(79,263) | $(103,238) |
| Adjustments to reconcile net loss - before NCI to net cash used in operating activities | ||
| Depreciation and amortization expense | 2,932 | 2,457 |
| Stock-based compensation | 11,139 | 19,532 |
| Gain on sale of intellectual property | (1,000) | — |
| APA-RDx: Issue common stock of majority-owned subsidiary - termination payment | 713 | 653 |
| Issue common stock - vendor service agreement | 625 | — |
| Change in fair value - Senior Secured Convertible Notes | 6,026 | 1,273 |
| Loss on issue - Senior Secured Convertible Note | 1,111 | 3,523 |
| Debt extinguishment loss - Senior Secured Convertible Note | 3,782 | 5,434 |
| Non-cash lease expense | 308 | 97 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (44) | 183 |
| Prepaid expenses, deposits and current and other assets | (246) | 397 |
| Accounts payable | (918) | (742) |
| Accrued expenses and other current liabilities | 2,799 | (554) |
| Net cash flows used in operating activities | (52,036) | (70,985) |
| Cash flows from investing activities | ||
| Purchase of equipment | (242) | (1,540) |
| Proceeds from sale of intellectual property | 1,000 | — |
| Asset acquisitions | — | (3,200) |
| Net cash flows provided by (used in) investing activities | 758 | (4,740) |
| Cash flows from financing activities | ||
| Proceeds – issue of preferred stock - majority-owned subsidiary | 18,625 | — |
| Proceeds – issue of Senior Secured Convertible Note | 10,000 | 35,227 |
| Payment – Senior Secured Convertible Note – acceleration floor payments | (79) | — |
| Proceeds – issue of common stock - At-The-Market Facility | 1,533 | 79 |
| Proceeds – majority-owned subsidiary common stock - Committed Equity Facility and At-The-Market Facility | 284 | 1,807 |
| Proceeds – exercise of stock options | — | 302 |
| Proceeds – issue common stock – Employee Stock Purchase Plan | 259 | 358 |
| Proceeds – majority-owned subsidiary common stock – Employee Stock Purchase Plan | 551 | 109 |
| Proceeds – exercise of stock options issued under equity plan of majority owned subsidiary | — | 695 |
| Purchase Treasury Stock – payment of employee payroll tax obligation in connection with stock-based compensation | — | (366) |
| Net cash flows provided by financing activities | 31,173 | 38,211 |
| Net increase (decrease) in cash | (20,105) | (37,514) |
| Cash, beginning of period | 39,744 | 77,258 |
| Cash, end of period | $19,639 | $39,744 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.